Xconomy

MAY 18, 2017

Preliminary findings from an economic impact study show that genomics is emerging as a distinct innovation cluster in San Diego. The San Diego Regional Economic Development Corp. began collecting data for the report earlier this year in a bid to assess how genomics fits into San Diego’s innovation economy.

Study 97

Study San Diego Venture Capital Press 97

Xconomy

JUNE 28, 2019

It was a relatively quiet week in the San Diego life sciences community, but local companies and organizations continue working away. —MEI Pharma, a late-stage cancer drug developer, presented updated data from a Phase 1b study of its lead drug candidate, ME-401, which is designed to inhibit a molecular pathway called PI3K delta.

San Diego 56

San Diego Study Design Organization 56

Xconomy

OCTOBER 15, 2018

Reflexion Health, which has developed a “virtual physical therapy” system for patients recovering from surgery, said results from a randomized controlled clinical trial completed by nearly 300 people showed patients who used the technology saved an average of $2,745 compared to those who underwent traditional physical therapy.

Study 83

Study San Diego Research Startup 83

Xconomy

JUNE 23, 2016

San Diego’s cybersecurity workforce has grown by nearly 15 percent over the past two years, according to a study released today by the Cyber Center of Excellence, a nonprofit industry group created to boost cybersecurity jobs and technologies in the region. The center also asked the San Diego Regional Economic Development Corp.

San Diego 69

San Diego Study Outsource Development Report 69

socalTECH

MARCH 30, 2015

A new study--driven by data collected by San Diego''s Lytx --finds that talking, texting, and. The study, released by the AAA Foundation for Traffic Safety , used videos of teen drivers provided by Lytx, to identify the distraction that led to crashes by teen drivers.

Study 100

Study San Diego Report Develop 100

socalTECH

NOVEMBER 22, 2021

San Diego-based medical visualization software developer LifeVoxel.AI LifeVoxel said it offers up aces to imaging studies and data, allowing for what it calls "4D interactive intelligent medical image views" over the Internet. announced this morning that it has raised $5M in a seed funding round.

Seed Funding 140

Seed Funding San Diego Study Software Development 140

Xconomy

AUGUST 31, 2016

Roger Tsien, a UC San Diego scientist who shared the 2008 Nobel Prize in chemistry for research that led to the development of fluorescent proteins used to illuminate tissue and track biological processes, has died, according to a statement from the university. He compared himself to John C.

San Diego 72

San Diego UCSD Avalon Study 72

socalTECH

NOVEMBER 7, 2011

San Diego-based ACADIA Pharmaceuticals reported this morning that the U.S. Food and Drug Administration has completed its review of the firm's New Drug Application for AM-831, its small molecule for treatment of schizophrenia, and it is advancing to Phase I clinical development. Ltd on the compound. Ltd on the compound.

Study 124

Study San Diego Report Develop 124

socalTECH

FEBRUARY 2, 2010

Search engine giant Google announced Tuesday that the firm is funding a number of University research projects, including a group of researchers at UC San Diego, a researcher at UC Santa Barbara, and a researcher in Los Angeles. Tags: google search engine research development.

Santa Barbara 150

Santa Barbara San Diego Research Google 150

socalTECH

NOVEMBER 9, 2020

San Diego-based Arcturus Therapeutics has received up to $220M in additional financial commitments from the country of Singapore, after receiving positive Phase 1/2 study results on one of its compounds. READ MORE>>.

Arcturus 113

Arcturus Study San Diego Funding 113

Xconomy

DECEMBER 20, 2018

New biopharma company Aristea Therapeutics has raised $15 million from Novo Holdings, the Danish investment company, and secured global rights to an investigational AstraZeneca drug that’s ready for Phase 2 study. The San Diego, CA, company made its public debut this week after starting up quietly earlier this year.

Develop 67

Develop Development San Diego Study 67

socalTECH

JULY 28, 2021

San Diego-based immunology startup Aristea Therapeutics says it has raised $63M in a Series B financing round, which was led by Fidelity Management & Research Company, LLC, along with Novo Holdings A/S, plus Arena Pharmaceuticals and funds managed by Tekla Capital Management, LLC. Mackay, Ph.D. is President and CEO of Aristea.

San Diego 100

San Diego Study Research Capital 100

Xconomy

JUNE 23, 2020

Reneo Pharmaceuticals has encouraging results from an early trial of a compound it is advancing for rare diseases characterized by impaired mitochondria—our cells’ energy generators—and the company says it is now designing a large global study of its drug candidate.

San Diego 127

San Diego Study Design Develop 127

socalTECH

SEPTEMBER 21, 2020

San Diego-based life sciences equipment maker Illumina announced this morning that it has acquired Menlo Park-based GRAIL , a developer of cancer early detection technology. GRAIL is developing a multi-cancer screening test. According to Illumina, it will acquire GRAIL for cash and stock worth $8 billion.

Artificial Inteligence 124

Artificial Inteligence San Diego Screening Study 124

socalTECH

JUNE 24, 2019

San Diego-based biopharmaceuticals startup AFYX Therapeutics announced this morning that it has raised $13M in a convertible loan financing. AFYX Therapeutics is developing treatments for mucosal diseases, with its lead compound aimed at treatment of oral lichen planus. The company is currently in an ongoing, Phase 2B study.

Study 113

Study San Diego Platform Invest 113

socalTECH

AUGUST 31, 2021

San Diego-based "ARS Pharmaceuticals, which is developing an epinephrine nasal spray designed to better treat severe allergic reaction, said today that it has raised $55M in a Series D funding.

Funding 113

Funding San Diego Study Design 113

Xconomy

SEPTEMBER 15, 2016

The Connect Innovation Report found that 405 software, technology, and life sciences startups were created last year in San Diego County. Software startups made up nearly 63 percent (255 companies created) of all new high-tech ventures created in 2015, a trend fueled chiefly by software app development, according to the report.

San Diego 40

San Diego Report High Tech Study 40

socalTECH

FEBRUARY 4, 2020

San Diego-based Plex Pharmaceuticals , which is developing antiviral drugs, says it has been awarded a $600,000 Phase I Small Business Innovation Research (SBIR) grant, specifically to develop antiviral drug candidates for the treatment of Dengue (DENV) fever, West Nile Virus (WNV) and Zika Virus (ZKV) infections.

San Diego 113

San Diego Study Research Develop 113

socalTECH

MARCH 28, 2019

San Diego-based biotech startup Biolinq , which is developing wireless-enabled biosensor patches for continuous monitoring of biomarkers, has raised $4.75M additional Series A funding, the company said this morning. The company said the new funding will go towards its technology platform, and to fund additional clinical studies.

Marketing 168

Marketing San Diego Venture Capital Study 168

Xconomy

APRIL 7, 2020

Inovio Pharmaceuticals, one of the biotechs developing a vaccine to prevent COVID-19, has received the FDA’s OK to start testing its candidate in healthy volunteers. The Plymouth Meeting, PA-based company, which also conducts research in San Diego, plans to enroll as many as 40 adults across two trial locations.

San Diego 108

San Diego Study Research Develop 108

socalTECH

MARCH 5, 2018

San Diego-based BioDuro , a life sciences contract research and development provider, announced this morning that it has acquired Molecular Response LLC , which provides a large collection of viable tumor specimens for the oncology market. Financial details of the buy were not announced. As part of thea cquisition, Thomas B.

Outsource Development 147

Outsource Development San Diego Study Research 147

Xconomy

MARCH 28, 2019

million from new investors, including the New York-based Juvenile Diabetes Research Foundation, following the results of a clinical study of its experimental biomarker monitoring device. Founders Jared Tagney and Joshua Windmiller, who met while in grad school at UC San Diego, started the company in 2012 as Electrozyme.

San Diego 103

San Diego Study Research Design 103

Xconomy

DECEMBER 18, 2019

More than 250 miles above the Earth’s surface aboard the International Space Station, a first-in-kind study of neurodegenerative disease is expected to reveal never-before-seen cell interactions.

Research 90

Research San Diego Study Funding 90

Xconomy

JULY 2, 2018

The test, sold by Genomic Health (NASDAQ: GHDX ) of Redwood City, CA, and developed by Epic Sciences of San Diego, is for men with a dangerous, Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Guide 81

Guide Study San Diego Journal 81

socalTECH

OCTOBER 23, 2019

San Diego-based Intrepida Bio , a biopharmaceuticals startup focused on developing medicines that modulate the innate immune system to fight cancer and other diseases, has raised $9.5M in a funding round, according to the company. The funding came from Sofinnova Investments and Canaan. Intrepedia was co-founded by Joel F.

San Diego 100

San Diego Study Funding Invest 100

socalTECH

OCTOBER 1, 2018

San Diego-based VelosBio , a biotech startup developing novel antibody-drug conjugates to treat hematological cancers and solid tumours, has raised $58M in a funding round. The Series A funding was led by Arix Bioscience, and also included Pappas Ventures, Chiesi Ventures, Takeda Ventures, and Decheng Capital. READ MORE>>.

San Diego 113

San Diego Study Funding Capital 113

Xconomy

OCTOBER 13, 2020

Gossamer Bio’s lead drug, an experimental treatment for asthma and allergies, has failed in two mid-stage clinical trials but the biotech sees enough in the data to pursue further development in a severe form of asthma and it wants to talk with regulators about advancing the compound to a larger Phase 3 study.

San Diego 82

San Diego Study Develop Development 82

socalTECH

NOVEMBER 7, 2018

San Diego-based Mirium Pharmaceuticals , which is developing treatments for rare liver diseases, announced on Wednesday morning that it has raised $120M in a Series A funding round. The company says it recently had a successful Phase 2b study. READ MORE>>.

San Diego 147

San Diego Study Capital Funding 147

socalTECH

APRIL 28, 2017

San Diego-based Epic Sciences has raised $40M in a Series D funding, for its cancer testing technology, the company announced Friday morning. Epic sciences is developing blood-based tests which help predict drug response in cancer. The company said the fund will go to accelerate clinical studies and enhance its technology.

Funding 153

Funding San Diego Study Capital 153

socalTECH

APRIL 1, 2020

San Diego-based Aspen Neuroscience , a biotechnology company developing treatments for Parkinson disease, said it has raised $70M in a Series A funding round. The funding was led by OrbiMed, and also included ARCH Venture Partners, Frazier Healthcare Partners, Domain Associates, Section 32, and Sam Altman.

San Diego 113

San Diego Screening Study Course 113

socalTECH

MAY 9, 2018

San Diego-based Escient Pharmaceuticals announced Wednesday morning that it has raised $40M in a Series A funding, to develop drugs to treat neuro-immuno-inflammatory and autoreactive diseases. Escient pharmaceuticals said it is developing drugs based on G Protein-Coupled Receptors (GPCRs). READ MORE>>.

San Diego 100

San Diego Study Funding Develop 100

Xconomy

NOVEMBER 11, 2019

A Roche drug in development as a treatment for spinal muscular atrophy achieved the main goals of a key study, helping to build the case that the drug could challenge a Biogen therapy already approved for the rare disorder. The Basel, Switzerland-based company plans to present full data from the study at a future medical conference.

Study 49

Study Conference Help Develop 49

Xconomy

FEBRUARY 26, 2020

About three years ago fledgling San Diego-based startup PvP Biologics announced a $35 million deal with Takeda Pharmaceutical that gave the Japan pharma giant rights to acquire the company down the line. The deal follows completion of a Phase 1 study evaluating the PvP drug. That day is here.

San Diego 72

San Diego Study Develop Development 72

socalTECH

JULY 24, 2017

San Diego-based eFFECTOR Therapeutics , a developer of treatments for cancer, has raised $38.6M eFFECTOR said the funding goes towards Phase 2 efforts for eFT508, the company's investigational small molecule MNK1/2 inhibitor, which is currently being studied for treating colerectal cancer. in total funding.

Study 113

Study San Diego Invest Funding 113

Xconomy

APRIL 22, 2019

Swiss pharma giant Novartis has invested $75 million in a $142 million Series C round for San Diego-based Poseida, which is one of several companies developing what is meant to be a one-time, long-lasting treatment for multiple myeloma. Multiple myeloma affects about 300,000 Americans every year.

San Diego 83

San Diego Study Funding Invest 83

Xconomy

MAY 5, 2020

Kura Oncology is discontinuing development of one of its three clinical-stage cancer drug candidates amid pandemic-related impacts to its clinical trial plans. The company had recently landed on a recommended Phase 2 dose of KO-947, and was preparing to test it in patients with head and neck squamous cell.

San Diego 63

San Diego Study Develop Development 63

socalTECH

DECEMBER 5, 2016

San Diego-based MabVax Therapeutics , which develops oncology drugs, said it is expanding a Phase I clinical trial for patients with pancreatic cancer.

San Diego 100

San Diego Study Research Sites 100